A gel-based proteomic analysis of the effects of green tea polyphenols on ovariectomized rats

Nutrition

Volumn 27, Issue 6, 2011, Pages 681-686

  Shao, Changxia ^a   Chen, Lixia ^a   Lu, Chuanwen ^a   Shen, Chwan Li ^b   Gao, Weimin ^a  

^a TEXAS TECH UNIVERSITY   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine triphosphate synthase; Catechol O methyltransferase; Green tea polyphenols; Osteoporosis; Superoxide dismutase 1; Two dimensional difference gel electrophoresis

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CATECHOL METHYLTRANSFERASE; COPPER ZINC SUPEROXIDE DISMUTASE; ESTROGEN; POLYPHENOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; LIVER; MASS SPECTROMETRY; NONHUMAN; OSTEOLYSIS; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; TEA; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; BONE DENSITY CONSERVATION AGENTS; CAMELLIA SINENSIS; CATECHOL O-METHYLTRANSFERASE; DIETARY SUPPLEMENTS; FEMALE; FLAVONOIDS; HUMANS; ISOENZYMES; LIVER; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; PEPTIDE FRAGMENTS; PHENOLS; PLANT LEAVES; PROTEOMICS; RANDOM ALLOCATION; RATS; RATS, INBRED F344; SUPEROXIDE DISMUTASE; TEA; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

RATTUS;

EID: 79955604901     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2010.05.019     Document Type: Article

References (47)

1. Bonura F. Prevention, screening, and management of osteoporosis: an overview of the current strategies. Postgrad Med 2009, 121:5-17.
2. McLeod K.M., Johnson C.S. Identifying women with low bone mass: a systematic review of screening tools. Geriatr Nurs 2009, 30:164-173.
3. Holroyd C., Cooper C., Dennison E. Epidemiology of osteoporosis. Best Pract Res Clin Endocrinol Metab 2008, 22:671-685.
4. Yang C.S., Landau J.M. Effects of tea consumption on nutrition and health. J Nutr 2000, 130:2409-2412.
5. Frei B., Higdon J.V. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 2003, 133:3275S-3284S.
6. Panza V.S., Wazlawik E., Ricardo Schutz G., Comin L., Hecht K.C., da Silva E.L. Consumption of green tea favorably affects oxidative stress markers in weight-trained men. Nutrition 2008, 24:433-442.
7. Shapiro H., Lev S., Cohen J., Singer P. Polyphenols in the prevention and treatment of sepsis syndromes: rationale and pre-clinical evidence. Nutrition 2009, 25:981-997.
8. Mildner-Szkudlarz S., Zawirska-Wojtasiak R., Obuchowski W., Goslinski M. Evaluation of antioxidant activity of green tea extract and its effect on the biscuits lipid fraction oxidative stability. J Food Sci 2009, 74:S362-S370.
9. Butt M.S., Sultan M.T. Green tea: nature's defense against malignancies. Crit Rev Food Sci Nutr 2009, 49:463-473.
10. Shen C.L., Wang P., Guerrieri J., Yeh J.K., Wang J.S. Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporos Int 2008, 19:979-990.
11. Banfi G., Iorio E.L., Corsi M.M. Oxidative stress, free radicals and bone remodeling. Clin Chem Lab Med 2008, 46:1550-1555.
12. Grassi F., Tell G., Robbie-Ryan M., Gao Y., Terauchi M., Yang X., et al. Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proc Natl Acad Sci U S A 2007, 104:15087-15092.
13. Pacifici R. Estrogen deficiency, T cells and bone loss. Cell Immunol 2008, 252:68-80.
14. Picherit C., Coxam V., Bennetau-Pelissero C., Kati-Coulibaly S., Davicco M.J., Lebecque P., et al. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J Nutr 2000, 130:1675-1681.
15. Shen C.L., Yeh J.K., Stoecker B.J., Chyu M.C., Wang J.S. Green tea polyphenols mitigate deterioration of bone microarchitecture in middle-aged female rats. Bone 2009, 44:684-690.
16. Timms J.F., Cramer R. Difference gel electrophoresis. Proteomics 2008, 8:4886-4897.
17. McNamara L.E., Dalby M.J., Riehle M.O., Burchmore R. Fluorescence two-dimensional difference gel electrophoresis for biomaterial applications. J R Soc Interface 2009, 7:S107-S118.
18. Van den Bergh G., Arckens L. Protein profiling based on two-dimensional difference gel electrophoresis. Methods Mol Biol 2008, 439:211-224.
19. Penque D. Two-dimensional gel electrophoresis and mass spectrometry for biomarker discovery. Proteomics Clin Appl 2009, 3:155-172.
20. Gao W.M., Chadha M.S., Berger R.P., Omenn G.S., Allen D.L., Pisano M., et al. A gel-based proteomic comparison of human cerebrospinal fluid between inflicted and non-inflicted pediatric traumatic brain injury. J Neurotrauma 2007, 24:43-53.
21. Burge R., Dawson-Hughes B., Solomon D.H., Wong J.B., King A., Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007, 22:465-475.
22. Gennari L., Merlotti D., De Paola V., Martini G., Nuti R. Bazedoxifene for the prevention of postmenopausal osteoporosis. Ther Clin Risk Manag 2008, 4:1229-1242.
23. Muraki S., Yamamoto S., Ishibashi H., Oka H., Yoshimura N., Kawaguchi H., et al. Diet and lifestyle associated with increased bone mineral density: cross-sectional study of Japanese elderly women at an osteoporosis outpatient clinic. J Orthop Sci 2007, 12:317-320.
24. Shen C.L., Yeh J.K., Cao J.J., Wang J.S. Green tea and bone metabolism. Nutr Res 2009, 29:437-456.
25. Sontakke A.N., Tare R.S. A duality in the roles of reactive oxygen species with respect to bone metabolism. Clin Chim Acta 2002, 318:145-148.
26. Reddy S.V. Regulatory mechanisms operative in osteoclasts. Crit Rev Eukaryot Gene Expr 2004, 14:255-270.
27. Smietana MJ, Kaushik A, Arruda EM, Faulkner JA, Larkin LM. The effect of reactive oxygen species on bone mineral density and bending stiffness in superoxide dismutase (SOD) knockout mice. FASEB J 2009, Meeting Abstracts 617.9.
28. Tatone C., Carbone M.C., Falone S., Aimola P., Giardinelli A., Caserta D., et al. Age-dependent changes in the expression of superoxide dismutases and catalase are associated with ultrastructural modifications in human granulosa cells. Mol Hum Reprod 2006, 12:655-660.
29. Furukawa Y., Torres A.S., O'Halloran T.V. Oxygen-induced maturation of SOD1: a key role for disulfide formation by the copper chaperone CCS. EMBO J 2004, 23:2872-2881.
30. Gao Z., Sarsour E.H., Kalen A.L., Li L., Kumar M.G., Goswami P.C. Late ROS accumulation and radiosensitivity in SOD1-overexpressing human glioma cells. Free Radic Biol Med 2008, 45:1501-1509.
31. Tanaka M., Mokhtari G.K., Terry R.D., Balsam L.B., Lee K.H., Kofidis T., et al. Overexpression of human copper/zinc superoxide dismutase (SOD1) suppresses ischemia-reperfusion injury and subsequent development of graft coronary artery disease in murine cardiac grafts. Circulation 2004, 110:II200-II206.
32. Meng Q., Velalar C.N., Ruan R. Effects of epigallocatechin-3-gallate on mitochondrial integrity and antioxidative enzyme activity in the aging process of human fibroblast. Free Radic Biol Med 2008, 44:1032-1041.
33. Miao L., St Clair D.K. Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med 2009, 47:344-356.
34. Noor R., Mittal S., Iqbal J. Superoxide dismutase-applications and relevance to human diseases. Med Sci Monit 2002, 8:RA210-RA215.
35. Sugawara T., Lewen A., Gasche Y., Yu F., Chan P.H. Overexpression of SOD1 protects vulnerable motor neurons after spinal cord injury by attenuating mitochondrial cytochrome c release. FASEB J 2002, 16:1997-1999.
36. Wakisaka Y., Chu Y., Miller J.D., Rosenberg G.A., Heistad D.D. Critical role for copper/zinc-superoxide dismutase in preventing spontaneous intracerebral hemorrhage during acute and chronic hypertension in mice. Stroke 2010, 41:790-797.
37. Roy A., Ganguly A., BoseDasgupta S., Das B.B., Pal C., Jaisankar P., et al. Mitochondria-dependent reactive oxygen species-mediated programmed cell death induced by 3,3'-diindolylmethane through inhibition of F0F1-ATP synthase in unicellular protozoan parasite Leishmania donovani. Mol Pharmacol 2008, 74:1292-1307.
38. Wang H.Q., Xu Y.X., Zhao X.Y., Zhao H., Yan J., Sun X.B., et al. Overexpression of F(0)F(1)-ATP synthase alpha suppresses mutant huntingtin aggregation and toxicity in vitro. Biochem Biophys Res Commun 2009, 390:1294-1298.
39. Reid I.R. Anti-resorptive therapies for osteoporosis. Semin Cell Dev Biol 2008, 19:473-478.
40. Isomura H., Fujie K., Shibata K., Inoue N., Iizuka T., Takebe G., et al. Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology 2004, 197:93-100.
41. Parl F.F., Dawling S., Roodi N., Crooke P.S. Estrogen metabolism and breast cancer: a risk model. Ann N Y Acad Sci 2009, 1155:68-75.
42. Lu H., Meng X., Yang C.S. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. Drug Metab Dispos 2003, 31:572-579.
43. Chen D., Wang C.Y., Lambert J.D., Ai N., Welsh W.J., Yang C.S. Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies. Biochem Pharmacol 2005, 69:1523-1531.
44. Gorai I., Inada M., Morinaga H., Uchiyama Y., Yamauchi H., Hirahara F., et al. CYP17 and COMT gene polymorphisms can influence bone directly, or indirectly through their effects on endogenous sex steroids, in postmenopausal Japanese women. Bone 2007, 40:28-36.
45. Eriksson A.L., Skrtic S., Niklason A., Hulten L.M., Wiklund O., Hedner T., et al. Association between the low activity genotype of catechol-O-methyltransferase and myocardial infarction in a hypertensive population. Eur Heart J 2004, 25:386-391.
46. Bonifacio M.J., Palma P.N., Almeida L., Soares-da-Silva P. Catechol-O-methyltransferase and its inhibitors in Parkinson's disease. CNS Drug Rev 2007, 13:352-379.
47. Levites Y., Youdim M.B., Maor G., Mandel S. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol 2002, 63:21-29.